APA (7th ed.) Citation

PT, D., V, P., A, S., I, K., A, G., H, P., . . . NA, V. (2020). Characteristics of Long-Term Survival in Patients With Myelodysplastic Syndrome Treated With 5-Azacyditine: Results From the Hellenic 5-Azacytidine Registry. Clinical lymphoma, myeloma & leukemia, 20(2), 114. https://doi.org/10.1016/j.clml.2019.09.614

Chicago Style (17th ed.) Citation

PT, Diamantopoulos, et al. "Characteristics of Long-Term Survival in Patients With Myelodysplastic Syndrome Treated With 5-Azacyditine: Results From the Hellenic 5-Azacytidine Registry." Clinical Lymphoma, Myeloma & Leukemia 20, no. 2 (2020): 114. https://doi.org/10.1016/j.clml.2019.09.614.

MLA (9th ed.) Citation

PT, Diamantopoulos, et al. "Characteristics of Long-Term Survival in Patients With Myelodysplastic Syndrome Treated With 5-Azacyditine: Results From the Hellenic 5-Azacytidine Registry." Clinical Lymphoma, Myeloma & Leukemia, vol. 20, no. 2, 2020, p. 114, https://doi.org/10.1016/j.clml.2019.09.614.